Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1991 Apr;82(4):448–455. doi: 10.1111/j.1349-7006.1991.tb01869.x

T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells

Takashi Nishimura 1,✉, Yuji Togashi 2, Nobutaka Wakamiya 3, Yoshiyuki Hashimoto 4, Hideo Yagita 5, Ko Okumura 5, Sonoko Habu 1
PMCID: PMC5918446  PMID: 1904424

Abstract

Lymphokine‐activated killer (LAK) cells, which can lyse a variety of tumor cells, can be induced from both normal and athymic nude mouse spleen cells by culture with high doses of recombinant interleukin 2 (rIL‐2). LAK cells generated from nude mouse spleen cells (Nude‐LAK cells) express just Thy 1.2 antigen, but not CD4 and CDS antigens. Nude‐LAK cells express neither T3 molecule, T cell receptor (TCR) αβ nor TCR γδ on their cell surface. The lack of TCR expression on Nude‐LAK cells was confirmed by the results of northern blot analysis. LAK cells generated from normal mouse spleen cells (Nor‐LAK) express TCR α, β transcripts, while Nude‐LAK cells express only sterile TCR β transcript, but not TCR α transcript. TCR γδ transcripts were scarcely detected in both Nor‐LAK cells and Nude‐LAK cells. Thus, it is strongly suggested that Nude‐LAK cells can recognize and lyse tumor cells by TCR‐independent mechanisms. Monoclonal antibody against lymphocyte function‐associated antigen (LFA‐1) molecule can block the Cytotoxicity of Nude‐LAK cells, indicating an important role of such accessory molecules in Nude‐LAK cell‐mediated Cytotoxicity.

Keywords: LAK cell, Nude mouse, T cell receptor, Lymphocyte function associatedantigen 1

Full Text

The Full Text of this article is available as a PDF (475.5 KB).

REFERENCES

  • 1. ) Grimm , E. A. , Mazumder , A. , Zhang , H. and Rosenberg , S. A.Lymphokine‐activated killer cell phenomenon. Lysis of natural killer‐resistant fresh solid tumors by interleukin 2 activated autologous human peripheral blood lymphocytes . J. Exp. Med. , 155 , 1823 – 1841 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Grimm , E. A. , Ramsey , K. M. , Mazumder , A. , Wilson , D. J. , Djeu , D. Y. and Rosenberg , S. A.Lymphokine‐activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus‐derived lymphocytes, and natural killer cells . J. Exp. Med. , 157 , 884 – 897 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Nishimura , T. and Hashimoto , Y.Induction of nonspecific killer T cells from non‐immune mouse spleen cells by culture with interleukin 2 . Gann , 75 , 177 – 186 ( 1984. ). [PubMed] [Google Scholar]
  • 4. ) Nishimura , T. , Yagi , H. , Uchiyama , Y. , and Hashimoto , Y.Generation of lymphokine‐activated killer (LAK) cells from tumor‐infiltrating lymphocytes . Cell. Immunol. , 100 , 149 – 157 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Mule , J. J. , Shu , S. , Schwarz , S. L. and Rosenberg , S. A.Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin 2 . Science , 225 , 1487 – 1489 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Mazumder , A. and Rosenberg , S. A.Successful immunotherapy of natural killer‐resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 . J. Exp. Med. , 159 , 495 – 507 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Nishimura , T. , Uchiyama , Y. , Yagi , H. and Hashimoto , Y , Slowly‐released administration of recombinant interleukin 2 Augmentation of the efficacy of the adoptive‐immuno‐therapy with lymphokine‐activated killer (LAK) cells . J. Immunol. Methods , 91 , 21 – 27 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Rosenberg , S. A. , Lotze , M. T. , Muul , L. , Leitman , S. , Chang , A. E. , Ettinghausen , S. E. , Matory , Y. E. , Skibber , J. M.Shiloni , E. , Vetto , J. , Seipp , C. A. , Simpson , C. and Reinchert , C. M.Observation on the systemic administration of autologous lymphokine‐activated killer cells and recombinant IL‐2 to patients with metastatic cancer . N. Eng. J. Med. , 313 , 1485 – 1492 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Yang , J. C. , Mule , J. J. and Rosenberg , S. A.Murine lymphokine‐activated killer (LAK) cells. Phenotypic characterization of the precursor and effector cells . J. Immunol , 137 , 715 – 726 ( 1986. ). [PubMed] [Google Scholar]
  • 10. ) Ortaldo , J. R. , Mason , A. and Overton , R.Lymphokineactivated killer cells. Analysis of progenitors and effectors J. Exp. Med. , 164 , 1193 – 1205 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Ferrini , S. , Miescher , S. , Zocchi , R. , Fliedner , V. V. and Moretta , A.Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)‐induced activated killer cells: analysis at the population and clonal levels . J. Immunol. , 138 , 1297 – 1302 ( 1987. ). [PubMed] [Google Scholar]
  • 12. ) Kalland , T , Belfrage , H. , Bhiladvala , P. and Hedlumd , G.Analysis of the murine lymphokine‐activated killer (LAK) cell phenomenon; dissection of effectors and progenitors into NK‐ and T‐like cells . J. Immunol , 138 , 3640 – 3645 ( 1987. ). [PubMed] [Google Scholar]
  • 13. ) Ballas , Z. K. , Rasmussen , W. and Otegham , J. K. V.Lymphokine‐activated killer (LAK) cells II. Delineation of distinct murine LAK‐precursor subpopulations . J. Immunol. , 138 , 1647 – 1652 ( 1987. ). [PubMed] [Google Scholar]
  • 14. ) Nishimura , T. , Yagi , H. , Uchiyama , Y. and Hashimoto , Y.Lymphokine‐activated cell‐associated antigen involved in broad‐reactive killer cell‐mediated cytotoxicity . Cell. Immunol , 94 , 122 – 132 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Borst , J. R. J. , Griend , V. D. , van Oostveen , J. W. , Ang , S‐L. , Melief , C. J. , Seidman , J. G. and Bolhuis , R. L. H.A T cell‐receptor γ/CD3 complex found on cloned functional lymphocytes . Nature , 325 , 683 – 688 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Brenner , M. B. , Mclean , J. , Sheft , H. , Riberdy , J. , Ang , S‐L. , Seidman , J. G. , Devlin , P.and Krangel, M. S. Two forms of the T‐cell receptor protein found on peripheral blood cytotoxic T lymphocytes . Nature , 325 , 689 – 694 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Moingenon , P. , Jitsukawa , S. , Faure , F. , Troalen , F. , Triebel , F. , Graziani , M. , Forestier , F. , Bellet , D. , Bohuon C. and Hercend , T.A γ‐chain complex forms a functional receptor on cloned human lymphocytes with natural killerlike activity . Nature , 325 , 723 – 726 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Nishimura , T. , Yagi , H. , Uchiyama , Y. and Hashimoto , Y.Recombinant interleukin 2 allows the differentiation of Thy 1.2+ LAK cells from nude mouse spleen cells . Immunol. Lett. , 12 , 77 – 82 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Nishimura , T. , Yagi , H. and Hashimoto , Y.The precursor cells of mouse lymphokine‐activated killer (LAK) cells . Thymus , 9 , 131 – 139 ( 1987. ). [PubMed] [Google Scholar]
  • 20. ) Yagi , H. , Nishimura , T. and Hashimoto , Y.Characteristics of mouse thymocyte‐derived interleukin 2‐activated killer cells and their precursors . Jpn. J. Cancer Res. , 78 , 721 – 728 ( 1987. ). [PubMed] [Google Scholar]
  • 21. ) Yoshikai , Y. , Rei , M. D. and Mak , T. W.Athymic mice express a high level of functional γ‐chain but greatly reduced levels of α‐ and β‐chain T‐cell receptor messages . Nature , 324 , 482 – 485 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Bank , J. , de Pinho , R. A. , Brenner , M. B. , Cassimeris , J. , Alt , F. W. and Chess , L.A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes . Nature , 322 , 179 – 181 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Lew , A. M. , Pardoll , D. M. , Maloy , W. L. , Fowlkes , B. J. , Kruisbeek , A. M. , Cheng , S‐F. , Germain , R. N. , Bluestone J. A. , Schwartz , R. H. and Coligan , J. E.Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes . Science , 234 , 1401 – 1405 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Nishimura , T. , Burakoff , S. J. and Herrmann , S. H.Protein kinase C required for cytotoxic T lymphocyte triggering . J. Immunol. , 139 , 2888 – 2891 ( 1987. ). [PubMed] [Google Scholar]
  • 25. ) Maniatis , T. , Fritson , E. F. and Sambrook , J. “ Molecular Cloning: A Laboratory Manual” ( 1982. ). Cold Spring Harbor Laboratory; , New York . [Google Scholar]
  • 26. ) Cerottini , J. C. and Brenner , K. T.Cell‐mediated cytotoxicity, allograft rejection, and tumor immunity . Adv. ImmunoL , 18 , 67 – 132 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Herberman , R. B. , Nunn , M. E. and Lavrin , D. H.Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity . Int. J. Cancer , 16 , 216 – 229 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Rosenberg , S. A.Lymphokine‐activated killer cells: a new approach to immunotherapy of cancer . J. Natl. Cancer Inst. , 75 , 595 – 603 ( 1986. ). [PubMed] [Google Scholar]
  • 29. ) Landegren , U. , Ramstedt , U. , Axberg , L , Ullberg , M. , Jondal , M. and Wigzell , H.Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu‐2a antibodies . J. Exp. Med. , 155 , 1579 – 1584 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. ) Platsoucas , C. D.Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector‐target cell binding and of the T3/Leu4 antigen with triggering . Eur. J. ImmunoL , 14 , 566 – 577 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Springer , T. A.Davignon , D. , Ho , H‐K. , Martz , E. and Sanchez‐Madrid , F.LFA‐1 and Lyt‐2, 3, molecules associated with T lymphocyte‐mediated killing; and Mac‐1, and LFA‐I homologue associated with complement receptor function . ImmunoL Rev. , 68 , 171 – 195 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Ikuta , K. , Hattori , M. , Wake , K. , Kano , S. , Honjo , T. , Yodoi , J. and Minato , N.Expression and rearrangement of the α, β and γ chain genes of the T cell receptor in cloned murine large granular lymphocyte lines No correlation with the cytotoxic spectrum . J, Exp. Med. , 164 , 428 – 442 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. ) Yanagi , Y. , Caccia , N. , Kronenberg , M. , Chin , B. , Roder , J. , Rohel , D. , Kiyohara , T. , Lauzon , R. , Toyonaga , B. , Rosenthal , K. , Dennert , K. , AchaOrbea , H. , Hengartner , H. , Hood , L. and Mak , T. W.Gene rearrangement in cells with natural killer activity and expression of the β‐chain of the T‐cell antigen receptor . Nature. 314 , 631 – 633 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Biron , C. A. , Elsen , P. V. D. , Tutt , M. M. , Medveczky , P. , Kumar , V. and Terhost , C.Murine natural killer cells stimulated in vivo do not express the T cell receptor α, βγ, T3δ orT3 genes . J. Immunol , 139 , 1704 – 1710 ( 1987. ). [PubMed] [Google Scholar]
  • 35. ) Triebel , F. , Graziani , M. , Faure , F. , Jitsukawa , S. and Hercend , T.Cloned human CD3 lymphocytes with natural killer‐like activity do not express nor rearrange T cell receptor gamma genes . Eur. J. Immunol , 17 , 1209 – 1212 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Itoh , K. , Tilden , B. , Kumagai , K. and Balch , C. M.Leu‐11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)‐induced activated killer (AK) cells . J. Immunol , 134 , 802 – 807 ( 1985. ). [PubMed] [Google Scholar]
  • 37. ) Sawada , H. , Abo , T. , Sugawara , S. and Kumagai , K.Prerequisite for the induction of lymphokine‐activated killer cells from T lymphocytes . J. Immunol , 140 , 3668 – 3673 ( 1988. ). [PubMed] [Google Scholar]
  • 38. ) Nishimura , T. , Yagi , H. and Hashimoto , Y.The role of lymphokine‐activated cell‐associated antigen II Distribution and correlation with cell cycle . Cell. Immunol , 107 , 24 – 31 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Nishimura , T. , Yagi , H. , Sato , N. , Ohta , S. and Hashimoto , Y , The role of lymphokine‐activated cell‐associated antigen III. Inhibition of T‐cell activation by monoclonal killer‐locking antibody . Cell. Immunol , 107 , 32 – 39 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 40. ) Pircher , H. , Groscurth , P. , Baumhutter , S. , Aguet , M. , Zinkernagel , R. M. and Hengartner , H.A monoclonal antibody against altered LFA‐1 induces proliferation and lymphokine release of cloned T cells . Eur. J. Immunol , 16 , 172 – 181 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Krensky , A. M. , Sanchez‐Madrid , F. , Robbins , E. , Nagy , J. A. , Springer , T. A. and BurakofF , S. J.The functional significance, distribution and structure of LFA‐1 LFA‐2 and LFA‐3: cell surface antigens associated with CTL‐target interactions . J. Immunol , 131 , 611 – 616 ( 1983. ). [PubMed] [Google Scholar]
  • 42. ) Shaw , S. , Luce , G. E. G. , Quinones , R. , Gress , R. E. , Springer , T. A. and Sanders , M. E.Two antigen‐independent adhesion pathways used by human cytotoxic T‐cell clones . Nature , 323 , 262 – 264 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 43. ) Shaw , S. and Luce , G. E. G.The lymphocyte function‐associated antigen (LFA)‐l and CD2/LFA‐3 pathways of antigen‐independent human T cell adhesion . J. Immunol , 139 , 1037 – 1045 ( 1987. ). [PubMed] [Google Scholar]
  • 44. ) Yagita , H. , Okumura , K. and Nakauchi , H.Molecular cloning of the murine homologue of CD2. Momology of the molecule to its human counterpart T11 . J. Immunol , 140 , 1321 – 1326 ( 1988. ). [PubMed] [Google Scholar]
  • 45. ) Yagita , H. , Nakamura , T. and Okumura , K.Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells . Proc. Natl. Acad. Sci. USA , 86 , 645 – 649 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Nishimura T. , Uchiyama , Y. and Hashimoto , Y.In vivo generation of lymphokine‐activated killer cells by sensitization with interleukin 2‐producing syngeneic T‐lymphoma cells . Cell. Immunol , 112 , 220 – 225 ( 1988. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES